Duodenal ferritin synthesis in genetic hemochromatosis. 1995

A Pietrangelo, and G Casalgrandi, and D Quaglino, and R Gualdi, and D Conte, and S Milani, and G Montosi, and L Cesarini, and E Ventura, and G Cairo
Dipartimento di Medicina Interna, University of Modena, Italy.

OBJECTIVE The molecular defect of genetic hemochromatosis (GH) is unknown. It is believed that low expression of duodenal ferritin in GH is caused by tissue or cell specific defect of ferritin synthesis. Our study was designed to ascertain whether the control of duodenal ferritin synthesis in GH was defective. METHODS Expression at the single cell level of H and L ferritin messenger RNAs and protein and activity of the iron regulatory factor, which controls the translation of ferritin messenger RNA, were assessed in 43 duodenal biopsy specimens from individuals with GH, secondary hemochromatosis (SH), anemia, or normal iron balance. RESULTS Signal for ferritin H and L subunit messenger RNAs was detected in both absorptive and nonabsorptive cells by in situ hybridization, but in 10 of 14 patients with untreated GH, the signal was lower than in patients with SH or normal subjects. However, immunostaining for ferritin protein documented a diffuse/cytoplasmic pattern, whereas a supranuclear/granular staining was found in normal subjects or patients with SH. The spontaneous activity of duodenal iron regulatory factor was consistently higher in patients with GH than in normal subjects or subjects with anemia or SH. CONCLUSIONS In patients with GH, ferritin gene transcription is preserved in both absorptive and nonabsorptive intestinal cells. Low accumulation of ferritin is not caused by a defective control of ferritin synthesis but by low expression of ferritin messenger RNA and sustained activity of iron regulatory factor.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004386 Duodenum The shortest and widest portion of the SMALL INTESTINE adjacent to the PYLORUS of the STOMACH. It is named for having the length equal to about the width of 12 fingers. Duodenums
D005293 Ferritins Iron-containing proteins that are widely distributed in animals, plants, and microorganisms. Their major function is to store IRON in a nontoxic bioavailable form. Each ferritin molecule consists of ferric iron in a hollow protein shell (APOFERRITINS) made of 24 subunits of various sequences depending on the species and tissue types. Basic Isoferritin,Ferritin,Isoferritin,Isoferritin, Basic
D006432 Hemochromatosis A disorder of iron metabolism characterized by a triad of HEMOSIDEROSIS; LIVER CIRRHOSIS; and DIABETES MELLITUS. It is caused by massive iron deposits in parenchymal cells that may develop after a prolonged increase of iron absorption. (Jablonski's Dictionary of Syndromes & Eponymic Diseases, 2d ed) Diabetes, Bronze,Bronze Diabetes,Bronzed Cirrhosis,Familial Hemochromatosis,Genetic Hemochromatosis,Haemochromatosis,Hemochromatoses,Iron Storage Disorder,Pigmentary Cirrhosis,Primary Hemochromatosis,Troisier-Hanot-Chauffard Syndrome,Von Recklenhausen-Applebaum Disease,Bronzed Cirrhoses,Cirrhoses, Bronzed,Cirrhoses, Pigmentary,Cirrhosis, Bronzed,Cirrhosis, Pigmentary,Disease, Von Recklenhausen-Applebaum,Diseases, Von Recklenhausen-Applebaum,Disorder, Iron Storage,Disorders, Iron Storage,Familial Hemochromatoses,Genetic Hemochromatoses,Haemochromatoses,Hemochromatose,Hemochromatoses, Familial,Hemochromatoses, Genetic,Hemochromatosis, Familial,Hemochromatosis, Genetic,Iron Storage Disorders,Pigmentary Cirrhoses,Recklenhausen-Applebaum Disease, Von,Recklenhausen-Applebaum Diseases, Von,Storage Disorder, Iron,Storage Disorders, Iron,Syndrome, Troisier-Hanot-Chauffard,Syndromes, Troisier-Hanot-Chauffard,Troisier Hanot Chauffard Syndrome,Troisier-Hanot-Chauffard Syndromes,Von Recklenhausen Applebaum Disease,Von Recklenhausen-Applebaum Diseases
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old

Related Publications

A Pietrangelo, and G Casalgrandi, and D Quaglino, and R Gualdi, and D Conte, and S Milani, and G Montosi, and L Cesarini, and E Ventura, and G Cairo
July 1982, The Journal of laboratory and clinical medicine,
A Pietrangelo, and G Casalgrandi, and D Quaglino, and R Gualdi, and D Conte, and S Milani, and G Montosi, and L Cesarini, and E Ventura, and G Cairo
November 1947, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
A Pietrangelo, and G Casalgrandi, and D Quaglino, and R Gualdi, and D Conte, and S Milani, and G Montosi, and L Cesarini, and E Ventura, and G Cairo
January 1990, Human heredity,
A Pietrangelo, and G Casalgrandi, and D Quaglino, and R Gualdi, and D Conte, and S Milani, and G Montosi, and L Cesarini, and E Ventura, and G Cairo
May 1976, The New England journal of medicine,
A Pietrangelo, and G Casalgrandi, and D Quaglino, and R Gualdi, and D Conte, and S Milani, and G Montosi, and L Cesarini, and E Ventura, and G Cairo
October 1991, Clinical and investigative medicine. Medecine clinique et experimentale,
A Pietrangelo, and G Casalgrandi, and D Quaglino, and R Gualdi, and D Conte, and S Milani, and G Montosi, and L Cesarini, and E Ventura, and G Cairo
February 1991, Deutsche medizinische Wochenschrift (1946),
A Pietrangelo, and G Casalgrandi, and D Quaglino, and R Gualdi, and D Conte, and S Milani, and G Montosi, and L Cesarini, and E Ventura, and G Cairo
April 1962, Revue francaise d'etudes cliniques et biologiques,
A Pietrangelo, and G Casalgrandi, and D Quaglino, and R Gualdi, and D Conte, and S Milani, and G Montosi, and L Cesarini, and E Ventura, and G Cairo
April 1989, Gastroenterology,
A Pietrangelo, and G Casalgrandi, and D Quaglino, and R Gualdi, and D Conte, and S Milani, and G Montosi, and L Cesarini, and E Ventura, and G Cairo
May 1977, The New England journal of medicine,
A Pietrangelo, and G Casalgrandi, and D Quaglino, and R Gualdi, and D Conte, and S Milani, and G Montosi, and L Cesarini, and E Ventura, and G Cairo
October 1976, Nutrition reviews,
Copied contents to your clipboard!